Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician’s Perspective
International Journal of Nanomedicine · 2026
DOI: 10.2147/ijn.s620995 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Hyeon-Jeong Jeon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Probiotics, Inflammatory Bowel Diseases, Extracellular Vesicles, Immunotherapy. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.
ORCID-Profile: Hyeon-Jeong Jeon
Zitieren
APA
Jeon, H. J., Choe, A. R., & Kim, S. E. (2026). Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician’s Perspective. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s620995
Vancouver
Jeon HJ, Choe AR, Kim SE. Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician’s Perspective. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s620995
BibTeX
@article{Jeon2026,
author = {Jeon, Hyeon-Jeong and Choe, A Reum and Kim, Seong-Eun},
title = {Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician’s Perspective},
journal = {International Journal of Nanomedicine},
year = {2026},
doi = {10.2147/ijn.s620995}
}
EUVIMED